Cargando…
Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies
BACKGROUND: Following the outbreak of COVID-19, global healthcare systems have had to rapidly adapt. People with multiple sclerosis (pwMS) were required to make decisions about their individual risk and consequent work and social behaviors. This study aimed to evaluate risk perception and patterns o...
Autores principales: | Beesley, R., Cauchi, M., Davies, L., Upcott, M., Norton, E., Loveless, S., Anderson, V., Wynford-Thomas, R., Pickersgill, T.P., Uzochukwu, E., Wardle, M., Robertson, N.P., Tallantyre, E., Willis, M.D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381979/ https://www.ncbi.nlm.nih.gov/pubmed/36088727 http://dx.doi.org/10.1016/j.msard.2022.104121 |
Ejemplares similares
-
Systemic complement profiling in multiple sclerosis as a biomarker of disease state
por: Ingram, G, et al.
Publicado: (2012) -
How to run a multiple sclerosis relapse clinic
por: Tallantyre, Emma C, et al.
Publicado: (2016) -
Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
por: Allman, M., et al.
Publicado: (2022) -
Continuous evolution of magnetic resonance imaging in multiple sclerosis
por: Tallantyre, E. C., et al.
Publicado: (2016) -
KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis
por: Hares, Kelly, et al.
Publicado: (2021)